References: |
1. Silverstein, F.E., et al. "Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study." JAMA. 284: 1247-1255 (2000). 2. Caldwell, B., et al. "Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis." J. R. Soc. Med. 99: 132-140 (2006). 3. Koki, A.T. and Masferrer, J.L. "Celecoxib: a specific COX-2 inhibitor with anticancer properties." Cancer Control. 9: 28-35 (2002). 4. Gierse, J.K., et al. "Kinetic basis for selective inhibition of cyclo-oxygenases." Biochem J. 339: 607-614 (1999). |